Role of ayurveda enema in heart disease

Not yet recruiting

• Conditions: Other heart disorders in diseasesclassified elsewhere,

• Registration Number: CTRI/2019/06/019784
• Lead Sponsor: DR LATISHA LAXMAN KOMARPANT

Brief Summary

The overall prevalence of moderate or severe Valvular Heart  disease is estimated at 2.5% with no sex difference, from 0.7% in those aged 18-44years to 13.3%in those aged<75years.

Valvular Heart Disease encompasses a condition which accounts for 10% to 20% all cardiac surgical procedures. In contemporary medical science the conservative measures taken to treat VHD has long term usage that has potential side effects with economic burden. Hence Basti treatment could be a safer, cost effective for the betterment of the patient.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-06-18
• Study Start: 2020-01-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• 1.Patient presenting with the Symptoms of VHD- Chest pain, dyspnoea, pedal oedema, fatigue.
• 2.K/C/O Valvular heart disease 3.Age between 20 – 70 years 4.Patient fit for basti.
• 5.On medication drugs will be continued.

Exclusion Criteria

Patients suffering from Valvular heart disease with: 1.Congestive cardiac failure (CCF) 2.Coronary Artery Disease (CAD).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Punarnavadi anuvasna basti effective in treating Valvular Heart Disease.	0th, 8th, 15th day

Secondary Outcome Measures

Name	Time	Method
Not Applicable	Not Applicable

Trial Locations

Locations (1)

KLE Ayurveda Hospital; 🇮🇳 Belgaum, KARNATAKA, India

KLE Ayurveda Hospital

🇮🇳Belgaum, KARNATAKA, India

DR LATISHA LAXMAN KOMARPANT

Principal investigator

9923466672

komarpantlatisha@gmail.com